| John G. Cox | President and Chief Executive Officer | FY2024 | |
| Douglas Kerr | Chief Medical Officer | FY2024 | |
| Oxana Beskrovnaya | Chief Innovation Officer; Former Chief Scientific Officer | FY2024 | |
| Richard Scalzo | Former Senior Vice President, Head of Finance and Administration | FY2024 | |
| Johanna Friedl-Naderer | Chief Commercial Officer | FY2025 | |
| Erick Lucera | Chief Financial Officer | Not disclosed | — |
6 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.